Nov 11, 2025 (PRISM News via COMTEX) --
BIO-key(R) International, Inc. (NASDAQ: BKYI), a leader in biometric authentication and Identity and Access Management (IAM) solutions, has been added to our PRISM Emerging Aerospace and Defense Index and Bio-key has announced a warrant inducement agreement with an existing institutional investor. This agreement involves the exercise of certain outstanding warrants originally issued on January 15, 2025.
Under the terms of the agreement, the investor will exercise Series A and Series B Warrants to purchase a total of 3,091,668 shares of BIO-key's common stock at a reduced exercise price of $1.02 per share. The transaction is subject to compliance with beneficial ownership blocker provisions outlined in the warrants. The gross proceeds from this exercise are anticipated to total approximately $3.1 million, before deducting placement agent fees and other offering expenses.
Maxim Group LLC is serving as the exclusive Placement Agent for this transaction.
As part of the agreement, BIO-key will issue the investor unregistered warrants to purchase an additional 6,183,336 shares of the Company's common stock at an exercise price of $1.02 per share (the "New Warrants"). These New Warrants are immediately exercisable and will remain valid for five years from the date of issuance. Additionally, BIO-key has committed to filing a registration statement with the Securities and Exchange Commission (SEC) to cover the resale of the shares of common stock issuable upon exercise of the New Warrants.
This announcement does not constitute an offer to sell or a solicitation to buy any securities, nor will any securities be sold in jurisdictions where such offers or sales would be unlawful without proper registration or qualification under applicable securities laws.
About BIO-key International, Inc.
BIO-key is transforming authentication and cybersecurity with its biometric-centric, multi-factor Identity and Access Management (IAM) solutions, securing access for over 40 million users worldwide. The company's PortalGuard IAM solution, available as a cloud-hosted or on-premise platform, offers cost-effective, secure, and convenient access to computers, applications, information, and high-value transactions. With options for phoneless, tokenless, and passwordless biometric authentication, BIO-key empowers customers to tailor authentication methods to diverse use cases.
To find out more about Bio-key please visit www.bio-key.com.
The post BIO-key International Secures $3.1 Million Through Warrant Inducement Agreement appeared first on PRISM MarketView.
COMTEX_470187090/2927/2025-11-11T13:30:44
